Recombinant Ald1 is a 36.8 kDa protein encoded by the ald1 gene (UniProt ID: Q5HFY4) . Key features include:
The enzyme’s activity is NAD⁺-dependent, and its structure is inferred to resemble bacterial alanine dehydrogenases with conserved catalytic residues .
Ald1 contributes to multiple pathways critical for S. aureus survival:
Generates L-alanine, a key component of peptidoglycan cross-linking .
ald1 mutants show reduced peptidoglycan integrity under stress, such as acetate intoxication .
Maintains intracellular alanine pools by balancing biosynthesis (via alanine racemase Alr1) and catabolism .
Supports carbon/nitrogen metabolism by linking amino acid degradation to the TCA cycle .
Upregulated during osmotic stress and nutrient limitation (e.g., acetate exposure) to sustain D-alanine production for cell wall repair .
Co-regulated with virulence factors (e.g., protein A, leukocidins) under SigS-dependent stress responses .
Ald1 expression is tightly controlled by transcriptional and post-transcriptional regulators:
Recombinant Ald1 is utilized in multiple research contexts:
Activity-based probes (e.g., JCP251-bT) selectively label Ald1 in live S. aureus, aiding in inhibitor screening .
Structural studies reveal conserved active sites, enabling rational drug design .
Used to study carbon/nitrogen flux in S. aureus using isotopic tracing (e.g., ¹³C-labeled alanine) .
Although not directly a vaccine antigen, Ald1’s role in virulence links it to adjuvant research targeting metabolic pathways .
Selectivity Issues: Ald1 shares functional redundancy with other dehydrogenases (e.g., Ald2), complicating knockout studies .
Structural Data Gap: No crystal structure of Ald1 is available, hindering mechanistic studies .
Therapeutic Potential: Small-molecule inhibitors (e.g., sulfonyl fluorides) show promise but require optimization for pharmacokinetics .
KEGG: sau:SA1272
What experimental approaches are used to determine Ald1’s role in d-alanine biosynthesis?
Methodology:
Isotope tracing: Use --l-alanine to track nitrogen retention in d-alanine via Ald1 activity (l-Ala → pyruvate → d-Ala via Dat) versus nitrogen loss via Ald1/Ald2-mediated pathways .
Genetic knockout: Construct ald1 mutants and quantify d-alanine pools using LC-MS/MS. Compare growth phenotypes in defined media with/without d-alanine supplementation .
Enzyme assays: Measure Ald1-specific activity via NAD-dependent oxidation of l-alanine to pyruvate (monitored spectrophotometrically at 340 nm) .
How does Ald1 contribute to redox balance in S. aureus?
Key mechanism: Ald1 catalyzes the reversible conversion of l-alanine to pyruvate, regenerating NAD during anaerobic growth.
Experimental validation:
How do transcriptional regulators like SigS influence ald1 expression under stress?
What contradictions arise when modeling Ald1’s role in genome-scale metabolic reconstructions?
Data conflicts:
How to resolve discrepancies in Ald1 activity assays across strains?
Troubleshooting:
Strain variability: Compare clinical isolates (e.g., USA300 vs. SH1000) for ald1 expression levels using qRT-PCR .
Cofactor specificity: Test NAD vs. NADP dependency across pH gradients (pH 6.0–8.5) .
Substrate competition: Assess inhibition by d-alanine or pyruvate analogs using Michaelis-Menten kinetics .
Why do ald1 mutants exhibit context-dependent essentiality?
How does Ald1 interact with the TCA cycle under respiratory vs. fermentative conditions?
Flux analysis:
For gene essentiality studies, use defined media (e.g., CDM) with controlled carbon/nitrogen sources to unmask conditional phenotypes .
In isotope tracing, combine -glucose and -l-alanine to decouple Ald1’s anabolic vs. catabolic roles .
Prioritize RNA-seq over microarrays for studying ald1 regulation due to SigS’s transient activation profile .